Categories
News

Camels test positive for respiratory virus in Kenya

A team of scientists surveyed 335 dromedary – single humped – camels from nine herds in Laikipia County, Kenya and found that 47% tested positive for MERS antibodies, showing they had been exposed to the virus. A new study has found that nearly half of camels in parts of Kenya have been infected by the virus that causes Middle East Respiratory Syndrome (MERS) and calls for further research into the role they might play in the transmission of this emerging disease to humans.

MERS was first identified in Saudi Arabia in 2012 and there is currently no vaccine or specific treatment available. To date, it has infected 1,595 people in more than 20 countries and caused 571 deaths. Although the majority of human cases of MERS have been attributed to human-to-human infections, camels are likely to be a major reservoir host for the virus and an animal source of MERS infection in humans.

A team of scientists from the University of Liverpool and institutions in the USA, Kenya and Europe, surveyed 335 dromedary – single humped – camels from nine herds in Laikipia County, Kenya and found that 47% tested positive for MERS antibodies, showing they had been exposed to the virus.

Professor Eric Fèvre, Chair of Veterinary Infectious Diseases at the University’s Institute of Infection and Global Health said: “Although Laikipia County camel density is low relative to more northern regions of Kenya, our study suggests the population is sufficient to maintain high rates of viral transmission and that camels may be constantly re-infected and serve as long term carriers of the virus. MERS in camels, it seems, is much like being infected by the common cold.

“The significance of this is not yet clear, because we don’t know if the virus is universally zoonotic. While the risk of these camels spreading MERS to humans cannot yet be discounted, it appears to be, for now, very low as there have been no human cases diagnosed in Kenya. “It might be that the mutations required to make this virus zoonotic have only evolved recently in the Middle East, where the human outbreaks have so far been concentrated.”

Lead author Dr Sharon Deem, Director of the Saint Louis Zoo Institute for Conservation Medicine, said: “Demand for livestock products, such as meat and milk, is rising across the globe and could offer poor farmers a route out of poverty as markets expand, but zoonotic disease remains a major obstacle to this goal. “Further research to determine whether the MERS virus is dangerous to humans in Kenya and other sub-Saharan countries is critical.

The full study is published in PLOS ONE.

http://www.sciencedaily.com/  Science Dail

http://www.sciencedaily.com/releases/2015/10/151017152244.htm  Original web page at Science Daily

Categories
News

Geographic distribution of MERS coronavirus among dromedary camels, Africa

We found serologic evidence for the circulation of Middle East respiratory syndrome coronavirus among dromedary camels in Nigeria, Tunisia, and Ethiopia. Circulation of the virus among dromedaries across broad areas of Africa may indicate that this disease is currently underdiagnosed in humans outside the Arabian Peninsula. A novel betacoronavirus, Middle East respiratory syndrome coronavirus (MERS-CoV), was identified as the cause of severe respiratory disease in humans during 2012. In August 2013, dromedary camels (Camelus dromedarius) were implicated for the first time as a possible source for human infection on the basis of the presence of MERS-CoV neutralizing antibodies in dromedaries from Oman and the Canary Islands of Spain. Since then, the presence of MERS-CoV antibodies in dromedaries has been reported in Jordan, Egypt, the United Arab Emirates, and Saudi Arabia. In October 2013, analysis of an outbreak associated with 1 barn in Qatar found dromedaries and humans to be infected with nearly identical strains of MERS-CoV. Further proof of widespread circulation of MERS-CoV among dromedaries was provided by studies from Egypt and Saudi Arabia. These findings have raised questions about the geographic distribution of MERS-CoV among camel populations elsewhere. Here, we report our assessment of the geographic distribution of MERS-CoV circulation among dromedaries in Africa by serologic investigation of convenience samples from these animals in Nigeria, Tunisia, and Ethiopia. Read more: http://wwwnc.cdc.gov/eid/article/20/8/14-0590_article

http://wwwnc.cdc.gov/eid/  Emerging Infectious Disease

http://wwwnc.cdc.gov/eid/article/20/8/14-0590_article  Original web page at Emerging Infectious Diseases

Categories
News

New hepatitis E virus genotype in camels, the Middle East

In a molecular epidemiology study of hepatitis E virus (HEV) in dromedaries in Dubai, United Arab Emirates, HEV was detected in fecal samples from 3 camels. Complete genome sequencing of 2 strains showed >20% overall nucleotide difference to known HEVs. Comparative genomic and phylogenetic analyses revealed a previously unrecognized HEV genotype. Hepatitis E virus (HEV) belongs to the family Hepeviridae and genus Hepevirus. Among humans worldwide, HEV is the most common cause of acute viral hepatitis. The disease is generally self-limiting, but mortality rates are high among pregnant women and young infants. Chronic HEV infection is a problem for immunocompromised patients, such as those who have received a solid organ transplant and those with HIV infection. In addition to humans, HEV has been found in the other mammals: pigs, boar, deer, rodents, ferrets, rabbits, mongoose, bats, cattle, sheep, foxes, minks, and horses. Among the 4 known HEV genotypes, HEV1 and HEV2 infect only humans; whereas, HEV3 and HEV4 can infect humans, pigs, and other mammals. Human infections with HEV3 and HEV4 have been associated with consumption of raw or undercooked pork or game meat. Traditionally, HEV infection is mainly transmitted through water contaminated with infected feces. Since water supplies and sanitary infrastructures have been improved, animals have become a major source of human HEV infection. We detected HEV in fecal samples from dromedary camels in the Middle East.

As part of a molecular epidemiology study, 203 fecal samples from 203 adult dromedaries (Camelus dromedarius) were submitted to the Central Veterinary Research Laboratory in Dubai, United Arab Emirates, over a 7-month period (January–July 2013). RNA extraction and reverse transcription were performed, as described, to detect other positive-sense single-stranded RNA viruses. Screening for HEV was performed by PCR amplification of a 284-bp fragment of open reading frame (ORF) 2 in HEV; specific primers used were 5′-TTTATTCTCGTCCAGTCGTTTC-3′ and 5′-GTCAGTGGAGGACCCATATGT-3′, designed from sequence information from our metagenomic study. PCR was performed according to previously described conditions; annealing temperature were set at 50°C. DNA sequencing and quantitative real-time reverse transcription PCR were also performed as described. Using strategies we have reported for other positive-sense single-stranded RNA viruses, we performed complete-genome sequencing on 2 HEV-positive samples. Comparative genomic analysis was performed as described. Phylogenetic analysis was conducted in MrBayes5D version 3.1.2 (www.fifthdimension.jp/products/mrbayes5d/) by using an optimal substitution model with 1 million Markov chain Monte Carlo generations; sampling was conducted every 100 generations with a burn-in of 25,000. The substitution model was selected on the basis of the corrected Akaike information criterion by ProtTest version 2.4 (http://darwin.uvigo.es/software/prottest.htmlExternal Web Site Icon).

http://wwwnc.cdc.gov/eid/  Emerging Infectious Diseases

June 24, 2014

http://wwwnc.cdc.gov/eid/article/20/6/14-0140_article.htm Original web page at Emerging Infectious Diseases

Categories
News

Viruses in humans and camels from one region are identical

Virologists Norbert Nowotny and Jolanta Kolodziejek from the Institute of Virology are investigating the transmission pathways of the MERS coronavirus. They found that viruses from infected humans and Arabian camels from the same geographical region have nearly identical RNA sequences. “This indicates transmission between animals and man. The process is referred to as zoonosis. With this knowledge we can specifically react to the spread of the virus. Vaccinations of camels are currently being discussed. We will thus be able to halt the spread of the virus,” said Nowotny. Virus RNA differs from region to region The scientists investigated nasal and conjunctival swabs, taken from 76 camels in Oman. In five camels they found the MERS coronavirus and compared its RNA with those of MERS coronavirus from Qatar and Egypt. The analysis showed that the viruses differ from region to region. “This means that there is no specific ‘camel MERS coronavirus strain’, but that one virus infects both, camels and humans,” says study coordinator Norbert Nowotny. Transmission pathway through nose and eyes.

Virus levels were surprisingly high in the nasal mucosa and conjunctiva of camels. Therefore the scientists presume that the transmission pathway from animals to humans most likely occurs through these contact sites, especially through nasal discharge. In man the virus causes severe pneumonia and renal failure while camels show no or very little symptoms (in some cases nasal discharge). So far all infections in humans have occurred in the Arabian Peninsula. However, some developed the disease after they returned to their native country, of whom eleven were from Europe. MERS coronavirus is also transmitted from one human to another, for instance in families, in the community, or through contact between patients and medical staff. MERS coronavirus is closely related to SARS coronavirus. SARS originated in China and claimed 800 lives worldwide in 2002 and 2003. “While the SARS coronavirus probably crossed the species barrier only once by passing from bats to humans, we may presume that the MERS coronavirus is being constantly transmitted from camels to humans,” explains Nowotny. The fact that MERS coronaviruses infect camels was shown by Nowotny and his colleagues in an earlier study, in which the scientists detected antibodies against the virus in the animals. The current genetic analysis of MERS coronarviruses permits more exact conclusions.

http://www.sciencedaily.com/  Science Daily

May 27, 2014

http://www.sciencedaily.com/releases/2014/05/140502081339.htm  Original webpage at Science Daily

Categories
News

Deadly MERS virus has infected camels at least since 1992

The Middle East respiratory syndrome (MERS) first made world headlines when it was discovered in 2012. But new research shows that the responsible virus has probably been lurking in camels in Saudi   Arabia since 1992 or even longer—and that it is very common among the animals today. The study suggests that undiscovered human cases may also have occurred the past 2 decades. MERS is caused by a coronavirus, a class of pathogens high on scientists’ watch list because another member, the severe acute respiratory syndrome (SARS) virus, spread around the globe in 2003, killing more than 700 people. The syndrome has sickened 182 and killed 80 people so far, but it does not seem to transmit from one person to the next as easily as SARS did. That suggests most patients acquired the virus from animals. SARS probably originated in bats and spread to humans via civets. But scientists investigating MERS are finding more and more evidence pointing to camels as the source. Last summer, researchers reported finding antibodies against the virus—signaling either a past or a current infection—in the blood of retired racing camels from Oman, but not in cows, goats, or sheep. Since then, studies have also reported such antibodies in camels from Qatar, Jordan, and Egypt. One study found antibodies against MERS in camel blood samples kept in cold storage in the United Arab Emirates since 2003. At least one team also found antibodies in recent samples from camels in Saudi Arabia, the country that has seen the majority of human cases. But many scientists are frustrated by how little information has emerged from that crucial country so far.

Studying the MERS virus has been fraught with other difficulties as well. For instance, importing samples from camels and other animals into the United States is hampered by fears of foot-and-mouth disease, a highly infectious disease that infects cloven-hoofed animals such as cattle and pigs; meanwhile, research resources in the affected countries in the Middle East are limited. To address both problems, ColumbiaUniversity virologist Ian Lipkin built a mobile lab and sent it to Saudi   Arabia late last year. “Two thermal cyclers, a robotic nucleic acid extractor, tools for serology, all this equipment went over there in six Pelican cases,” he says. Together with Saudi colleagues, the researchers used the equipment to test 203 camels from different parts of Saudi   Arabia. They found antibodies against the MERS virus in 150 of them. They also discovered the virus’s RNA in rectal or nasal swabs from 51 animals, a sign that they were harboring the virus at the time of testing. Viral sequences closely matched those from human patients. Because the nasal swabs yielded the most virus, the most likely scenario is airborne transmission of the pathogen, the authors write in mBio today. The researchers also looked at more than 100 camel serum samples from an archive going back to 1992 and found antibodies against MERS in almost all of them. “This virus has clearly been in camels since at least 1992,” Lipkin says.

The paper adds to the growing evidence on the animal reservoir of MERS, says Marion Koopmans, an infectious disease researcher at the National Institute of Public Health and the Environment in Bilthoven, the Netherlands. “It is now undisputable that these viruses circulate among dromedary camels,” she writes in an e-mail. Bart Haagmans, a virologist at Erasmus MC in Rotterdam, the Netherlands, says he is surprised that viral RNA could be found in so many of the animals. “You don’t expect to find a virus for a respiratory infection in almost one in four animals,” he says. It suggests that the virus knows how to maintain itself in the camel population very well. It’s not clear whether the virus actually makes camels sick, but it seems to infect many camels at a young age, Haagmans says. Most scientists agree that studies looking at infected camels over time are needed to find out how long they can harbor virus. Finding antibodies in 22-year-old samples raises the question of why the first known human patients date from 2012, Koopmans says. “Have human cases been missed before, or has something changed in the camel viruses that makes them transmit to humans?” To resolve that question, scientists would have to look at more old samples from Middle Eastern patients with respiratory illness—and those aren’t available, she writes. Whether MERS has been infecting humans for 2 decades or 2 years, there is still a real danger that it will start spreading between people more rapidly and trigger a pandemic, says Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, Twin Cities. “We’re now at the second level of concern,” he says, because MERS is not just a dangerous virus in animals but is spilling over into the human population again and again. “The third level could happen tomorrow.”

http://news.sciencemag.org/sciencenow  ScienceNow March 2014-03-05

http://news.sciencemag.org/health/2014/02/deadly-mers-virus-has-infected-camels-least-1992  Original web page at ScienceNow

Categories
News

Replicative capacity of MERS Coronavirus in livestock cell lines

Replicative capacity of Middle East respiratory syndrome coronavirus (MERS-CoV) was assessed in cell lines derived from livestock and peridomestic small mammals on the Arabian Peninsula. Only cell lines originating from goats and camels showed efficient replication of MERS-CoV. These results provide direction in the search for the intermediate host of MERS-CoV. Coronaviruses (CoV) in the genera Alphacoronavirus and Betacoronavirus (order Nidovirales, family Coronaviridae, subfamily Coronavirinae) infect a broad range of mammals, including humans. The human CoVs (HCoVs) HCoV-HKU1, HCoV-229E, HCoV-NL63, and HCoV-OC43 typically cause mild to moderate respiratory tract infection; however, the disease course can be more severe in a minority of patients. In 2002–2003, an epidemic of severe lower respiratory tract infection with a case-fatality rate of ≈10% was caused by severe acute respiratory syndrome (SARS)–CoV. In 2012, another CoV associated with severe respiratory disease emerged on the Arabian Peninsula and was termed Middle East respiratory syndrome (MERS)–CoV.

Both SARS-CoV and MERS-CoV are zoonotic viruses, and their presumed origin is in bats. SARS-related CoVs were identified in Rhinolophus spp. bats in China and Europe, and MERS-related CoVs were found in Pipistrellus bats in Europe and in Neoromicia bats in South Africa. As with SARS-CoV, it is expected that MERS-CoV might be transmitted to humans by an intermediate animal host, and neutralizing antibodies against MERS-CoV have been found in Arabian camels originating from Oman, Spain, and Egypt. We investigated replication of MERS-CoV in cell lines of the most abundant mammalian livestock species and representative peridomestic small mammals on the Arabian Peninsula. To estimate MERS-CoV permissiveness of cell cultures derived from these animals, we compared MERS-CoV replication and infectious virus production with that in bat- and primate-derived cells known to be permissive for MERS-CoV. The MERS-CoV receptor dipeptidyl peptidase 4 (DPP-4) is expressed in epithelial cells of the lung and kidney, and patients with MERS-CoV consistently show severe involvement of both organs; thus, we focused on lung and kidney cells in potential animal hosts.

Emerging Infectious Diseases
January 21, 2014

Original web page at Emerging Infectious Diseases

Categories
News

To swallow or to spit? New medicines for llamas, alpacas

South American camelids, especially llamas and alpacas, are very susceptible to infections caused by endoparasites. The so-called small liver fluke (Dicrocoelium dendriticum) is particularly problematic and infections with this parasite are frequently fatal. Moreover, camelids are prone to stress and together with their tendency to spit (especially when they do not like the taste of something) this very often results in underdosing if they are given medicine to swallow. Inadequate treatment of endoparasites leads to progression of the pathological changes and can be lethal for the animals. Underdosing of antiparasitic drugs may also lead to the emergence of anthelmintic resistance. Two scientists from the Vetmeduni Vienna now report a solution. Agnes Dadak from the Institute of Pharmacology and Sonja Franz from the Clinic for Ruminants have jointly developed a palatable paste that the animals swallow willingly and that allows the administration of highly concentrated drugs in small volumes. Drugs that are already approved for use in other species but not available in a concentration appropriate for use in llamas and alpacas can be incorporated in the paste in the correct dose. To treat small liver fluke, the vets added the drug praziquantel to the paste to give a final dose of 50mg/kg body weight. This extremely high dose turns out to be exactly right for the successful treatment of the disease in camelids. Administering drugs orally to camelids has significant advantages.

Topical treatment of the animals is generally ineffective because of their thick skin, which is not easily permeated by drugs. Furthermore, many active substances cannot be provided as injections due to their chemical characteristics. “Our paste seems to be extremely useful in treating the animals. We are now working on incorporating other important drugs for use against different diseases in llamas and alpacas,” says pharmacologist Dadak. Llamas and alpacas are normally kept in herds, so it makes sense to treat the entire stock if an infection with the small liver fluke is detected. “We are happy to make our experience and scientific knowledge of camelids available to people who keep these animals, as well as to veterinary surgeons. Our development provides a scientifically sound basis for ensuring the health of the animals,” says ruminant expert Franz.

Science Daily
November 12, 2013

Original web page at Science Daily

Categories
News

Lack of in-depth studies hampers efforts to identify source

Possible infection with the MERS coronavirus, or a closely related virus, has been detected in camels. A year on from the first reported human case of infection with Middle East respiratory syndrome coronavirus (MERS-CoV), the world still has few answers to the most pressing question from a public-health perspective: what is the source of the steady stream of new cases? Only with this information can the outbreak be controlled. There have so far been 114 confirmed cases of MERS-CoV infection, including 54 deaths, with another 34 suspected cases. All originated in the Arabian Peninsula, with most in Saudi Arabia and others in Jordan, Qatar and the United Arab Emirates (UAE). Imported cases have occurred in the United Kingdom, France, Italy and Tunisia. The virus is thought to be an animal virus that sporadically jumps to people — there are no signs yet that it can spread easily between humans, although limited spread between people in close contact has been seen.

But a lack of epidemiological studies means that the source of the virus is still unknown. This is “absolutely unacceptable”, says Michael Osterholm, head of the University of Minnesota’s Center for Infectious Disease Research and Policy in Minneapolis. Affected countries have to some extent lacked a sense of urgency, agrees Jean-Claude Manuguerra, head of the Laboratory for Urgent Response to Biological Threats at the Pasteur Institute in Paris. They have also tended to consider it a sovereign issue that is the business of national authorities, not outsiders, he adds. Manuguerra was one of 13 international health experts invited by the Saudi Arabian government and the World Health Organization (WHO) in Geneva, Switzerland, to visit the country in June as part of a joint mission to assess the situation and recommend measures to control the outbreak. He contrasts the lack of progress on MERS epidemiology with China’s rapid and robust response following the report in March of the first human cases of a new H7N9 avian influenza virus, which quickly identified live-bird markets as the main route of human infections and moved swiftly to shut them down. To identify a source of infection, patients must be questioned in detail about their recent activities, such as whether they visited animal markets or farms, or ate certain foods, to find patterns and leads for investigation. But the joint Saudi–WHO mission concluded that such work has not been detailed enough to accomplish this.

Also insufficient, the mission said, were efforts to look for the virus in animal populations, which would enable transmission routes to humans to be shut down. Bats are likely to have been the original source: the genome sequence of the MERS virus is closest to that of other bat corona­viruses. Since this discovery, Saudi Arabia has twice invited a team led by Ian Lipkin, a virologist at Columbia University in New York, to sample bat tissue and faeces, and in August the team published a partial sequence that seems to match that of MERS1 (see Nature http://doi.org/ntk; 2013). But direct contact with bats is unlikely to explain the human cases, and scientists suspect that the virus has infected other animals that are more likely to come into contact with people. Some say they are baffled that affected countries have not carried out large-scale sampling of animals to look for the virus. Ziad Memish, Saudi Arabia’s deputy minister of health, says that his country has been waiting for advice about testing from the Rome-based United Nations Food and Agriculture Organization (FAO) and the World Organisation for Animal Health in Paris.

Juan Lubroth, the FAO’s chief veterinary officer, says that its first expert mission to assess possible animal sources left last weekend for Saudi Arabia and the UAE. There will be several more, he adds, and the FAO hopes to work with national authorities to start epidemiological studies within months. A tantalizing clue to a possible animal source comes from two studies on camels. Both found antibodies to MERS or a closely related virus in camels in neighbouring countries to those affected, indicating past infection. Neither found live virus in the animals, however. “It is possible that such a virus is ubiquitous, but from time to time is undergoing crucial mutations that allow limited cross-species jumps from the intermediate host to humans,” says Malik Peiris, a virologist at the University of Hong Kong and a co-author of one of the studies. That was the scenario with the exotic coronavirus SARS that emerged in Hong Kong in late 2002 and evolved to become a virus that spread easily between humans, killing almost 800 people before dying out in July 2003. With millions soon to be on the move for the hajj, the annual pilgrimage to Mecca in mid-October, the Saudi authorities are on high alert for suspected cases of MERS, and will no doubt be hoping that MERS is not the next SARS.

Nature
October 1, 2013

Original web page at Nature

Categories
News

Decoding the genome of the camel

By sequencing the genome of a Bactrian camel, researchers at the Vetmeduni Vienna have made a significant contribution to population genetic research on camels. The study has laid the foundation for future scientific work on these enigmatic desert animals. A blood sample from a single Bactrian camel with the evocative name of “Mozart” provided the genetic raw material for the work, which was undertaken by Pamela Burger at the Institute of Population Genetics. Camels are divided into two species, the one-humped dromedary and the two-humped Bactrian camel. Whether equipped with one or two humps, camels are precious in desert regions throughout the world. Their ability to carry heavy loads over long distances makes them ideally suited for transportation. In addition, camels are able to survive for weeks in hostile environments without food and water. Despite the extremely arid conditions, camels still provide enough milk for human consumption and also have an important role as a source of meat. Camels are specialists when it comes to adapting to the environment and have been characterized as sustainable food producers.

Pamela Burger heads one of the few research groups in Europe that study camel genetics. Burger and her colleagues are primarily interested in the domestication of camels, which took place around 3,000 to 6,000 years ago. Genetic data provide important clues on the breeding strategies and selection processes that were applied by humans at that time. The DNA code also represents a rich resource for addressing questions on phylogenetic relationships between animals. Burger is one of the first scientists to sequence large parts of the genome of a Bactrian camel and make it available to the public. Until recently, the genetic code of the Camel had not been fully analysed. Genetic research on these animals was therefore difficult or even impossible. In contrast, the entire genetic information of the human genome was available as long ago as 2003 and the genetic code of various animals and plants is publicly available, giving researchers access to an enormous set of data. To date, the lack of basic genetic data has severely hampered studies of camel genetics. Pamela Burger and her team are pioneers in presenting this essential dataset.

The scientists were able to find 116,000 so-called SNPs (single nucleotide polymorphisms) in the genetic sequence of the Bactrian camel. SNPs are single base-pair changes within a DNA strand that provide the basis for studying relationships among species and between single animals. The genetic relationship between the Bactrian camel (Camelus bactrianus) and the dromedary (Camelus dromedarius) is close. 85 per cent of the genomic sequences expressed in the dromedary can be found in the Bactrian camel. Burger explains, “Mozart’s genome provides us with the basis for further comparative research on other camelids such as dromedary, lama and alpaca.”

Science Daily
June 11, 2013

Original we page at Science Daily

Categories
News

Relocating elephants backfires

You can move an elephant, but you can’t make him stay. After monitoring a dozen bull Asian elephants in Sri Lanka that were transferred—three of them multiple times—to national parks, researchers have concluded that relocation neither reduces human-elephant conflicts nor helps conservation efforts. Indeed, five of the translocated elephants ended up being killed within 8 months of their release, and the elephants killed five people. “The Department of Wildlife Conservation (DWC) has been transferring elephants for many years,” says Prithiviraj Fernando, a wildlife biologist at the Centre for Conservation and Research in Rajagiriya, Sri Lanka, and the lead author of the new study. “But it was never known what really happens to them.” To find out, in 2004, Fernando, his colleagues from the Smithsonian Conservation Biology Institute in Front Royal, Virginia, and DWC began monitoring those animals that the wildlife department identified as “problem elephants.” All were adult males, and all had been caught raiding crops, breaking into houses, or injuring people. Some had killed people by trampling them.

Asian elephants (Elephas maximus) number between 35,000 and 50,000 individuals, and are found in highly fragmented populations in 13 south and Southeast Asian countries. They are extinct in 78% of their historic range, and are listed as an endangered species on the Red List of the International Union for Conservation of Nature. Six thousand elephants remain in Sri Lanka; some 70% of these live outside of protected areas. Each year, more than 70 people and 200 elephants die as a result of human-elephant conflicts. Because of the elephants’ endangered status and Sri Lankan sociocultural sensitivities, wildlife managers prefer to relocate problem animals, rather than kill them, Fernando says. “The practice was thought to mitigate human-elephant conflicts, and help conserve elephants.” But that’s not what his team found. The 12 elephants that Fernando and his colleagues monitored were all captured by DWC officials outside of protected areas. The elephants were darted with tranquilizers and monitored by veterinarians, who also treated any existing wounds. Each elephant was fitted with a collar that collected the animal’s GPS location every 4 or 8 hours. The scientists and their DWC colleagues also put GPS collars on 12 elephants that lived partly or completely outside the parks, 10 of whom were also identified as problem elephants, but were not translocated. These “resident” elephants served as a control. Each animal in the two groups was then tracked for periods of up to 3 years.

The relocated elephants fell into one of three groups: Those that tried to return to their original stomping grounds; those that left the parks and wandered far afield; and those that stayed in their new homes. There were only four of these settlers; five were wanderers, and three homers, as the scientists called them. Brigadier was a typical “wanderer.” Released in Maduru Oya National Park, he left the area the next day and traveled almost 96 kilometers before reaching the sea. He continued his journey, swimming another 5 kilometers, but was recaptured by the Sri Lanka navy and returned to shore. He settled in another region, continued to cause problems, and eventually fell into a well and died. Homey, another translocated elephant, set off for home three times from three different national parks. He died 15 months after his first move from multiple gunshot wounds. Even relocated elephants that seemed to settle in the parks sometimes made excursions to raid village crops outside. Some broke through the parks’ electric fences or traversed deep trenches that were designed to keep the jumbos inside. “These barriers were useless,” Fernando says. Four of the elephants boldly entered major towns, causing havoc, injuring and killing people, damaging homes and vehicles, and killing a water buffalo. All dramatically increased the size of their home ranges: the areas that they live and travel in. Whereas the 12 resident elephants had home ranges of 282 square kilometers, the relocated elephants had areas that averaged 1090 square kilometers. From the moment of their release, these elephants were basically trying to go home, the researchers report today in PLOS ONE. “The translocations actually increased the problems with the problem elephants, ” Fernando says. “They walked over huge areas that were unfamiliar to them, causing problems for themselves and for people. As an elephant management tool, translocation did not help the elephants or the people.”

In stark contrast, none of the resident problem elephants traveled long distances or killed people, although one was shot dead for raiding. African elephant researchers are not surprised by the results. “Translocation has become a popular method of dealing with intransigent human-elephant conflict,” says Joyce Poole, an ethologist and expert on elephant behavior in Nairobi, who directs the conservation organization ElephantVoices. “Previous studies in Africa have demonstrated the increased mortality and likelihood that translocated elephants will walk hundreds of kilometers back home. But as this important paper documents, the effort is counterproductive and should be abandoned. It only serves to push the problem elsewhere.”

ScienceNow
January 8, 2013

Original web page
at ScienceNow

Categories
News

Bactrian camel genome holds survival secrets

Sky-high blood glucose levels, a diet loaded with salt and a tendency to pack away fat sounds like a recipe for a health disaster in a human. But in a Bactrian camel, these are adaptations that may help it survive in some of the driest, coldest and highest regions of the world. Researchers in Mongolia and China have begun to unravel the genomic peculiarities behind the physiological tricks that camels use to survive in the harshest of conditions. In a paper published today in Nature Communications, the scientists describe the draft genomes of wild and domesticated Bactrian camels. When they first explore a new genome, geneticists are most interested in the ‘rapidly evolving’ sections. These hot zones of activity typically contain genes that define the species, coding for the characteristics that set it apart from its closest relatives. “We found that many genes related to metabolism are under accelerated evolution in the camel, compared with other even-toed ungulates such as cattle,” says Yixue Li, director of the Shanghai Center for Bioinformation Technology in China and a co-author of the paper.

Camels, as ruminants like cattle and sheep, digest food by chewing the cud. But many of the Bactrian genome’s rapidly evolving genes regulate the metabolic pathway, suggesting that what camels do with the nutrients after digestion is a whole different ball game. “It was surprising to me that they had significant difference in the metabolism,” says Kim Worley, a molecular geneticist at Baylor College of Medicine in Houston, Texas. The differences could point to how Bactrians produce and store energy in the desert. The work shows that camels can withstand massive blood glucose levels owing in part to changes in genes that are linked to type II diabetes in humans. The Bactrians’ rapidly evolving genes include some that regulate insulin signalling pathways, the authors explain. A closer study of how camels respond to insulin may help to unravel how insulin regulation and diabetes work in humans. “I’m very interested in the glucose story,” says Brian Dalrymple, a computational biologist at the Queensland Bioscience Precinct in Brisbane, Australia.

The researchers also identified sections of the genome that could begin to explain why Bactrian camels are much better than humans at tolerating high levels of salt in their bloodstreams. In humans, the gene CYP2J controls hypertension: suppressing it leads to high blood pressure. However, camels have multiple copies of the gene, which could keep their blood pressure low even when they consume a lot of salt, suggest the authors of the latest work. This rough analysis is only the start of the investigation into the camel genome. “There are interesting titbits for future work,” says Max Rothschild, an animal genomicist at Iowa State University in Ames.

Nature
November 27, 2012

Original web page at Nature

Categories
News

Nerve-growth protein linked to ovulation

A chemical in llama semen responsible for inducing ovulation in females has been identified and, surprisingly, it is a protein already known for its role in promoting the growth and survival of nerve cells in many species. The protein — nerve growth factor (NGF) — is also found in human semen, suggesting that it may play a previously unsuspected role in human fertility. Whereas many animals, including humans, cattle and mice, produce eggs as part of a cycle of spontaneous ovulation, others — including llamas, camels, rabbits and koalas — are ‘induced ovulators’ that need a chemical stimulus. In 2005, Gregg Adams, a veterinary surgeon and reproductive scientist at the University of Saskatchewan in Saskatoon, Canada, and his colleagues showed that in llamas, the stimulus was in the seminal fluid. In the latest study, published this week in the Proceedings of the National Academy of Sciences, Adams led a team that identified the chemical as NGF. Although human women do not require NGF in semen to ovulate, Adams says that the protein could still have a direct effect on human fertility. Earlier this year, he published a paper showing that llama seminal fluid shortens the ovulation cycles of cows and seems to stimulate the development of the corpus luteum — a structure inside the ovaries that forms after an egg has been released and secretes hormones vital to pregnancy.

In some cases, NGF could explain why some couples find it difficult to conceive, says Warren Foster, a reproductive biologist at McMaster University in Hamilton, Canada. Adams agrees: a couple could have fertility problems if either the man failed to produce enough NGF in his semen or the woman lacked the receptors to detect and respond to it, he says. Previous research has already shown that NGF and similar proteins are made in human ovaries and have a local effect on how the eggs develop, says Sergio Ojeda, a neuroscientist at Oregon Health and Science University in Portland. But Adams believes the latest study indicates that seminal NGF may be acting like a hormone — making its way through the walls of the vagina, into the blood and all the way to the brain, where it stimulates the release of other hormones that affect the ovaries. “The beauty of this paper was that they weren’t looking for NGF,” says Ojeda. The research, he says, is “extremely exciting because, in the past, the scientific community has sometimes been guilty of only going with the established dogma”.

Nature
September 4, 2012

Original web page at Nature

Categories
News

Natural Burkholderia mallei infection in dromedary, Bahrain

We confirm a natural infection of dromedaries with glanders. Multilocus variable number tandem repeat analysis of a Burkholderia mallei strain isolated from a diseased dromedary in Bahrain revealed close genetic proximity to strain Dubai 7, which caused an outbreak of glanders in horses in the United Arab Emirates in 2004. Glanders, a World Organisation for Animal Health (OIE)–listed disease, is a contagious, life-threatening disease of equids caused by the gram-negative bacterium Burkholderia mallei. Although eliminated in western Europe, glanders remains endemic to several Asian, African, and South American countries. It recently reappeared in Pakistan and Brazil in 2008 and 2009, respectively, and appeared for the first time in Kuwait and Bahrain in 2010. Natural B. mallei infections are known to occur in various mammals (e.g., cats, bears, wolves, and dogs). Camels are also susceptible to B. mallei, as experimental infection has demonstrated. We report a natural infection of dromedaries (Camelus dromedarius).

An outbreak of glanders is ongoing in equids in Bahrain. Most of the reported cases were found in Saar and Shakhoura in the Northern governorate. Samples from 4,843 horses and 120 donkeys were sent to the OIE Reference Laboratory at the Central Veterinary Research Laboratory in Dubai, United Arab Emirates. Of these samples, 45 horses with clinical signs consistent with glanders were positive by complement fixation test and were euthanized along with 4 donkeys that also had positive test results. In addition to horses and donkeys, dromedaries showed clinical signs of glanders, but B. mallei infection has not yet been confirmed. Here we provide evidence for a B. mallei infection in 1 of the diseased dromedaries.

Emerging Infectious Diseases
July 12, 2011

Original web page at Emerging Infectious Diseases

Categories
News

Hospital infections: Unique antibody from Llamas provide weapon against Clostridium Difficile

Clostridium difficile is a health problem that affects hundreds of thousands of patients and costs $10 billion to $20 billion every year in North America. Researchers from the University of Calgary and the National Research Council of Canada say they are gaining a deeper understanding of this disease and are closer to developing a novel treatment using antibodies from llamas. “We have found that relatively simple antibodies can interfere with the disease-causing toxins from C. difficile,” says paper co-author Dr. Kenneth Ng, an associate professor of biological sciences at the University of Calgary and principal investigator of the Alberta Ingenuity Centre for Carbohydrate Science. “This discovery moves us a step closer to understanding how to neutralize the toxins and to create novel treatments for the disease.” His research is part of a paper published March 18 in the print issue of the Journal of Biological Chemistry. Approximately two percent of all patients admitted to hospital may be infected by C. difficile, which thrives when healthy bacteria in the gut are weakened by antibiotics, thus allowing spores from Clostridium to germinate and colonize the large intestine.

“This research is significant because C. difficile is an increasing heath care problem and many people may experience multiple infections,” says Dr. Glen Armstrong, head of the Department of Microbiology, Immunology, and Infectious Diseases in the Faculty of Medicine at the University of Calgary. “The current treatments are becoming less effective and C. difficile is developing resistance to conventional antibiotics. This research promises to provide a much-needed alternate treatment option that will overcome the failings of conventional antibiotics.” C. difficile produces two toxins — toxin A (TcdA) and toxin B (TcdB) — which cause damage to intestinal cells by binding to carbohydrates on the cell surface and disrupting cell functions such as adhesion. The new research shows that what’s known as single-domain antibodies bind to the C. difficile toxins with high affinity and interfere with the toxins’ ability to damage cells.

“Llamas have normal antibodies like our own, but they have also developed a second type of antibody with a simpler structure. It is this simpler structure that allows us to make modifications and perform many detailed studies that are not easily done with other types of antibodies,” says Ng. “The unique characteristics of these single-domain antibodies provide an attractive approach for developing new treatments for C. difficile.” These single-domain antibodies were discovered in 1993 in camelids, which include llamas and camels. Camelids produce conventional antibodies found in all mammals as well as heavy-chain antibodies from which single-domain antibodies are derived. These single-chain antibodies are 10 times smaller than those found in humans and can be more readily engineered into a drug. Dr. Jamshid Tanha, the corresponding author of the study from the National Research Council in Ottawa says that understanding how camelid antibodies work will ultimately allow researchers to develop a new treatment for this important disease and potentially others. “We are currently working with Dr. Ng’s group to determine why these antibodies are successful,” says Tanha.

Science Daily
April 5, 2011

Original web page at Science Daily

Categories
News

Llama proteins could play a vital role in the war on terror

Scientists at the Southwest Foundation for Biomedical Research (SFBR) have for the first time developed a highly sensitive means of detecting the seven types of botulinum neurotoxins (BoNTs) simultaneously. The BoNT-detecting substances are antibodies — proteins made by the body to fight diseases — found in llamas. BoNT are about 100 billion times more toxic than cyanide, and collectively, they are the only toxins in the federal Centers for Disease Control and Prevention (CDC) ‘category A’ list of potential bioterror threats alongside anthrax, Ebola virus and other infectious agents. The llama antibodies, called single domain antibodies (sdAb) or “nanobodies,” are molecularly flexible, unlike conventional antibodies. “As such, sdAb may allow biosensors to be regenerable and used over and over without loss of activity. Also, for some types of BoNT, conventional antibodies are not generally available and we are filling this biosecurity gap,” said Andrew Hayhurst, Ph.D., an SFBR virologist. Since some sdAb have been shown to have inhibitory activity and can block toxin function, they may play a role as part of a future anti-botulism treatment.

The new work, funded by the Defense Department’s Defense Threat Reduction Agency Medical Diagnostics Program, is described in the Jan. 21 issue of the journal PLoS ONE. BoNTs are made by specific strains of the bacterium Clostridium, which are widely distributed in soils and aquatic sediments. Most cases of botulism are the result of improperly stored foods, which can encourage growth of Clostridia and production of toxin, which is then ingested. BoNTs are extremely potent and target the nervous system, resulting in paralysis that can be so severe as to require life support on a mechanical ventilator for weeks to months. Countermeasures to prevent and treat botulism, such as vaccines and therapeutics, are extremely limited. Consequently, the ability to detect these toxins in the environment is critically important. “We not only aim to use the antibodies in BoNT detection tests, but also to understand how they bind and inhibit these fascinating molecules,” Hayhurst said. “We are also striving to improve our test by making it more sensitive such that one day it may be able to detect much smaller amount of toxins found in patients’ blood. Since BoNT also have therapeutic applications with carefully controlled preparations and dosing regimens, there is also an increasing need to monitor BoNT levels in these treatments.”

In the new study, a llama was immunized with harmless versions of seven types of BoNT, blood taken to provide antibody producing cells. Using bioengineering techniques, the antibody genes were cloned and the resulting antibodies were tested for their ability to detect BoNT in a selection of drinks, including milk. Hayhurst and his team are continuing to study the molecular interactions of the llama antibodies to find out why they are so specific and why some of them inhibit toxins. The laboratory capabilities of SFBR enabled this research to be performed according to all applicable federal guidelines of biosafety and biosecurity under the CDC Select Agent Program.

Science Daily
February 9, 2010

Original web page at Science Daily

Categories
News

Peru volcano spews deadly ash

Clouds of poisonous ash and acidic smoke from a volcano in southern Peru are causing severe respiratory problems for people and animals living in the mountain’s shadow. Locals have been wearing face masks to keep from breathing ashes and fumes, and some have even bestowed the protection on their livestock. The Ubinas volcano sits in the Moquegua region near the southern tip of Peru. It has been inactive since 1969 but began periodically spewing smoke and ash earlier this month. Yesterday the volcano sent a plume of gases more than half a mile (about one kilometer) into the air, sparking local officials to declare an alert for the region and order evacuations.

Hundreds of people have reported eye and respiratory ailments, and some animals have died from eating grass covered in volcanic ash, including 20 llamas. “The cows and the lambs don’t want to eat,” Lucia Condori, a villager living 2.5 miles (4 kilometers) south of the volcano, told the Reuters news agency. Many villagers are refusing to leave their homes unless they can take their livestock with them.

National Geographic
May 9, 2006

Original web page at National Geographic